
Journal of Medicinal Chemistry p. 2453 - 2460 (1994)
Update date:2022-08-03
Topics:
Knoerzer
Nichols
Brewster
Watts
Mottola
Mailman
Racemic trans-10,11-dihydroxy-5,6,6a,7,8,12b- hexahydrobenzo[a]phenanthridine (2, dihydrexidine) was shown previously to be the first bioavailable full efficacy agonist at the D1 dopamine receptor. In addition to its full D1 agonist
View MoreHeliosense Biotechnologies, Inc.
website:https://www.heliosense.com/
Contact:+86-592-5667290
Address:Xiamen Torch Hi-tech Zone Venture Weiye Building S506
Taizhou Shengxing Chempharm Co.,Ltd
Contact:+86-576-88516600
Address:Yantou Chemical Zone Jiaojiang Taizhou Zhejiang China
Shanghai KFSL Pharmaceutical Technology Co.,Ltd.
Contact:+86-21-39971718
Address:859 jiadingchengliu shanghai
Beijing Greenchem Technology Co.,Ltd. ( Panjin Greenchem Technology Co.Ltd .)
website:http://www.bjgreenchem.com/
Contact:+86-427-6515887
Address:301,302, 3rd Floor, Building C-7, Dongsheng Science Park, Northern Territory, Zhongguancun, No. 66, Xixiaokou Road, Haidian District, Beijing
Shanghai PotentPharm Science and Technology Co.,Ltd
Contact:86-021-51969655
Address:Unit B, Building 18, No.300, Chuantu Rd,Pudong District, Shanghai 201202, China
Doi:10.1002/hlca.19640470753
(1964)Doi:10.1021/ml500187a
(2014)Doi:10.1039/c8sc00233a
(2018)Doi:10.1021/jo0103930
(2001)Doi:10.1021/ja953545f
(1996)Doi:10.1016/0040-4020(96)00323-7
(1996)